Showing 206 results

Filters Content type: News, Editors' picks Topic: People with limited treatment options

HIV treatment for people who have a strain of HIV that is resistant to multiple drug classes or who cannot take other HIV medications.

Access to healthcare

Third-line ARVs could widen treatment gap in Zimbabwe

Editor's pick
IRIN Plus News
12 March 2013
People with limited treatment options

New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy

News
10 March 2013
New & experimental HIV treatments

Can people with resistant HIV omit NRTIs when switching from a failing regimen?

News
7 March 2013
Resistance

Prevalence of drug-resistant HIV has fallen dramatically among antiretroviral-experienced patients in Western Europe

News
22 January 2013
Treatment outcomes & life expectancy

Australian researchers project that many HIV-positive people will run out of treatment options

News
22 January 2013
People with limited treatment options

Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure

News
8 January 2013
People with limited treatment options

Redefining Expanded Access Programs for patients with MDR-HIV

Editor's pick
GMHC Treatment Issues
4 December 2012
Changing treatment

Raltegravir-resistant HIV stays susceptible to dolutegravir in lab

Editor's pick
International AIDS Society
13 November 2012
Generic medicines

The generic generation

News
22 October 2012
Resistance

Mutation breaks HIV's resistance to drugs

Editor's pick
Science Daily
14 September 2012
People with limited treatment options

Booster HIV Drug Can Be Dropped

Editor's pick
MedPage Today
13 September 2012
Diabetes

Glucose metabolism worsens in HIV treatment-experienced taking NRTI-sparing regimens

News
24 August 2012
People with limited treatment options

Once-daily elvitegravir works as well as raltegravir at 96 weeks

News
31 July 2012
New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
New & experimental HIV treatments

EACS: Does Maraviroc Intensification Promote Better CD4 Cell Recovery?

Editor's pick
HIVandhepatitis.com
27 October 2011
People with limited treatment options

HIV Drug Resistance Effect Damped Down over Time

Editor's pick
MedPage Today
10 October 2011
New & experimental HIV treatments

Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

Editor's pick
The Body
21 September 2011
People with limited treatment options

Low stock: HIV patients denied second-line drugs

Editor's pick
Times of India
7 August 2011
New & experimental HIV treatments

Once-daily elvitegravir matches raltegravir

News
21 July 2011
People with limited treatment options

Is there a future for HIV-infected patients in deep salvage?

Editor's pick
The Body
4 May 2011
People with limited treatment options

Cipla seeks voluntary license for anti-HIV Isentress

Editor's pick
Moneycontrol.com
4 April 2011
People with limited treatment options

Cipla seeks voluntary license for anti-HIV Isentress

Editor's pick
4 April 2011
New & experimental HIV treatments

What Lies Ahead: An Activist's View of Promising HIV Treatment Research

Editor's pick
The Body
31 March 2011
People with limited treatment options

Zambia: 'Only Four Percent Need Third Line ARV Treatment'

Editor's pick
AllAfrica
15 March 2011